Healthcare and Life Science
Call for glaucoma classification tool to be used nationally
Glaucoma is the most frequent cause of irreversible blindness but up to 40 per cent of patients could be missing out on crucial social support, warn Cambridge experts who hope their free technology will be embraced by clinicians nationally. ...
ELRIG announces keynote speakers for Drug Discovery 2025
Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”Event supported by VisitBritain showcases UK life science sector and extends international reachCambridge, UK, 07 May 2...
PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics
Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive DirectorStrategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platformCambridge, UK, 7 May 2025: PhoreMost...
Trilobio raises $8M to deliver whole lab automation for biologists
San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized Capital, including participation from Argon Ventures and L...
Why the UK life sciences sector must collaborate with China: Insights from Cedrik Neike’s perspective
Cedrik Neike, Managing Board Member of Siemens AG and CEO of Siemens Digital Industries, has provided a compelling perspective on the indispensable role China plays in maintaining the global competitiveness of German industry. ...
PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial
Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries Safety and functionality data for the updated Liquid Biopsy System supports continuation of the BIOPATTERN trial ...
Nuclera establishes distribution network across APAC and the Middle East
Operational expansion accelerates global distribution capability to increase regional access and technical supportMultiple partnerships establish direct distribution channels in China, Japan, South Korea, Singapore and IsraelCambridge, UK, and Boston MA, USA, 06 May 2025: Nuclera, the b...
Deloitte 2025 Technology Fast 50: The fastest growing tech companies in the UK Applications now open!
We’re delighted to announce that nominations for the 2025 UK Technology Fast 50 awards are now open! Apply today and you could join the likes of Deliveroo, Revolut and Skyscanner as a UK Technology Fast 50 winner. Application deadline: Midnight, Friday 27 June 2025 ...
People, science and building biotech
Anne Horgan, Partner at Cambridge Innovation Capital, talks about what makes her tick as an investor. She will chair the discussion on Nailing the Fundraise at BioBeat25 [hyperlink]. Co-organisers, Alisa Molotova, Start-up Mentor, and Miranda Weston-Smith, BioBeat founder chat with h...
Robot-assisted double operation is an Addenbrooke’s first
A cancer patient who underwent the first robot-assisted double operation at Addenbrooke’s Hospital said on Tuesday 29th April “I was blown away by how fast it was all over.” ...